Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00668434
Other study ID # R01AR053960
Secondary ID R01AR053960
Status Completed
Phase Phase 2
First received April 25, 2008
Last updated April 9, 2015
Start date November 2008
Est. completion date September 2013

Study information

Verified date April 2015
Source Kaiser Permanente
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Sciatica is a condition that causes a sharp, burning pain in the back, buttock, and leg. The condition is caused by injury to or compression of the sciatic nerve, which is located in the back of the leg. This study will determine the effectiveness of the steroid prednisone in decreasing pain and improving function in people with sciatica.


Description:

Sciatica is most often caused by a herniated disc in the lumbar region of the back and results from inflammation of the nerve roots as they exit the spine. It is a very common cause of back and leg pain, loss of function, and inability to work. Although sciatica is common, the effectiveness of current treatments is limited. Epidural steroid injections (ESIs), which can reduce inflammation of the nerve roots, are commonly used to decrease sciatica pain and restore normal function in patients. The exact effectiveness of ESIs, however, is unknown. If inflammation, and not compression, is the main cause of sciatica, it is reasonable to consider giving the steroid orally rather than by injection. If oral steroids prove effective, patients and clinicians will have access to a simple, inexpensive therapy that can be prescribed by primary care physicians without delay. This study will determine the effectiveness of the oral steroid prednisone in decreasing pain and improving function in people with sciatica.

Participants in this study will attend a screening visit at which they will answer questions about their health to determine eligibility, undergo a neurologic exam, and have a plain lower spine x-ray. An MRI of the lower spine will be performed for those who meet clinical eligibility. Participants whose MRI shows that a disc has ruptured in a specific way will be randomly assigned to receive either a 15-day course of prednisone capsules or a 15-day course of placebo capsules. Participants will take their assigned study medications in addition to their usual pain medications.

At Week 3, participants will return for a follow-up visit during which they will answer questions about their pain and general health and wellness. Participants who are still having considerable pain will be offered an epidural steroid injection (ESI) as a part of the study. At Week 6, participants will be called at home for a telephone interview and again answer questions about their general health and wellness; this telephone call will last about 20 minutes. If they continue to have considerable pain, they will be offered a second ESI as part of the study.

At Week 12, an interviewer will phone participants to determine if their pain has decreased and whether they have been able to return to their normal activities. The telephone contact will last about 20 minutes. Additional information about their back problems will be obtained from their medical records and from Kaiser Permanente's computerized medical records on their use of health care and medicines for back problems. At Week 24, participants will attend an evaluation visit at the Spine Clinic to assess their progress and symptoms. At Week 52 (1 year from randomization), participants will undergo a final telephone interview.


Recruitment information / eligibility

Status Completed
Enrollment 269
Est. completion date September 2013
Est. primary completion date September 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Seeks care at a Kaiser Permanente clinic spine care specialist at the San Jose, Redwood City, or Roseville site

- Complains of low back pain and functionally incapacitating leg pain extending below the knee with a nerve root distribution

- Score of at least 20 on the modified Oswestry Disability Index

- Appears, in the opinion of the study physician, to be very likely to have a herniated lumbar disc

- MRI study confirms a herniated disc consistent with the signs and symptoms

Exclusion Criteria:

- Onset of sciatica symptoms occurred more than 3 months before study entry

- Cauda equina syndrome

- Active cancer

- Acute spinal fracture

- Currently taking oral steroids

- Diabetes mellitus and taking insulin or glycohemoglobin greater than 10%

- Systolic blood pressure greater than 180 mm Hg or diastolic blood pressure greater than 110 mm Hg

- Pregnant or breastfeeding

- Active peptic ulcer disease

- History of intolerance to steroid therapy

- Bleeding diathesis or anticoagulant therapy

- Ongoing litigation or workers compensation claim for low back pain or sciatica

- Underwent previous lumbar surgery

- Received epidural steroid injection (ESI) within the 12 months before study entry

- Unable to read or speak English

- Progressive or severe motor loss

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Prednisone
For participants who weigh 50 kg or more, the prednisone dose will be 60 mg daily for 5 days, then 40 mg daily for 5 days, and then 20 mg daily for 5 days. For participants who weigh less than 50 kg, the dose will be 40 mg daily for 10 days, and then 20 mg daily for 5 days.
Placebo
Placebo capsules will look the same as the study medication but will not contain active medicine.

Locations

Country Name City State
United States Kaiser Permanente Northern California, Redwood City Redwood City California
United States Kaiser Permanente Roseville California
United States Kaiser Permanente Northern California, San Jose San Jose California

Sponsors (2)

Lead Sponsor Collaborator
Kaiser Permanente National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oswestry Disability Index, v2 The Oswestry Disability Index, v2 is a back-pain-specific measure of disability and functional status. It is measured on a 0-to-100 scale, with higher numbers indicating greater disability. Baseline, Week 3 follow-up No
Secondary Pain Numerical Rating Scale Ordinal scale of average level of pain as perceived by the participant over the prior 3 days; measured on a 0-to-10 scale, with higher numbers indicating greater pain. Baseline, Week 3 follow-up No
Secondary Oswestry Disability Index, v2 The Oswestry Disability Index, v2 is a back-pain-specific measure of disability and functional status. It is measured on a 0-to-100 scale, with higher numbers indicating greater disability. Baseline, Week 52 follow-up No
Secondary Pain Numerical Rating Scale Ordinal scale of average level of pain as perceived by the participant over the prior 3 days; measured on a 0-to-10 scale, with higher numbers indicating greater pain. Baseline, Week 52 follow-up No
See also
  Status Clinical Trial Phase
Completed NCT02384928 - Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation N/A
Completed NCT05626140 - COMPARISON OF EFFICACY OF DIFFERENT DRUG COMBINATIONS IN ACUTE SCIATICA Phase 3
Withdrawn NCT02313350 - Intradiscal Discogel® in Resistant Sciatica N/A
Unknown status NCT02512081 - "The Lived Experience of Investigations for Sciatica" N/A
Recruiting NCT06179901 - The Effect of Early MSAT Treatment on Sciatica Caused by Traffic Accidents N/A
Terminated NCT02951377 - Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy Phase 1
Completed NCT03347929 - NSAIDs in Sciatica NSAIDS IN SCIATICA Phase 4
Completed NCT04145310 - BOL-DP-o-04 in Patients With Low Back Pain and Sciatica Phase 1/Phase 2
Enrolling by invitation NCT04660656 - Predictive Value of the Five-repetition Sit-to-stand Test After Lumbar Spine surgerySTS-3 Study.
Completed NCT02644421 - Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica) Phase 1
Completed NCT00991172 - A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain Phase 2
Completed NCT00749996 - Herniectomy Versus Herniectomy With a Spinal Stabilization System for the Treatment of Complex Disc Disease Phase 4
Completed NCT00246948 - The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial N/A
Completed NCT04155450 - Effects of Extension Biased External Limb Loading in Addition to McKenzie Extension Protocol in Lumbar Derangement Syndrome N/A
Completed NCT02284542 - NAPS: Non-awake Versus Awake Placement of Spinal Cord Stimulators
Recruiting NCT02770963 - Efficacy of Acupuncture for Discogenic Sciatica N/A
Completed NCT00364572 - Efficacy of Epidural Etanercept in the Treatment of Sciatica Phase 1/Phase 2
Completed NCT00470509 - Adalimumab in Severe and Acute Sciatica Phase 2
Active, not recruiting NCT03887962 - Virtual Environment Rehabilitation for Patients With Motor Neglect Trial N/A
Completed NCT05959317 - Effects of Pilates Exercises and Neural Dynamic Mobilization in Sciatica Patients N/A